176 Fungal Infections
• Fungi can cause significant human disease.
• Human fungal infection is overwhelmingly caused by the following organisms: Aspergillus, Blastomyces, Candida, Coccidioides, Cryptococcus, Histoplasma, Paracoccidioides, Sporothrix, and Zygomycetes.
• Fungal infection rates have dramatically increased after the arrival of improved diagnostic capabilities and a growing population of immunosuppressed patients.
• Invasive fungal infections carry an extremely high mortality rate, and recognition with rapid treatment by an observant emergency physician prevents morbidity.
General Epidemiology
The risk of fungal infections is tied to both geography and immune status. Immunocompromised individuals are exponentially more likely to suffer from fungal infection. Immunocompetent patients do acquire significant, often invasive fungal disease, especially in endemic areas. In 3 counties in the southwestern United States, coccidioidomycosis in immunocompetent patients who were more 65 years old occurred with an incidence of 40 in 100,000. In addition to the best-known endemic areas, smaller areas in Africa and Asia are known to harbor pockets with high rates of infection. Fungal infections are a scourge in hospitals, and they account for significant numbers of nosocomial infections. Previously published data showed that 10% of all nosocomial infections were fungal,1 and Candida was responsible for 85% of those infections.2
Presenting Signs and Symptoms
No specific presenting signs or symptoms are pathognomonic of fungal infection. Certain patient populations are more likely to contract fungal infections (Table 176.1).
PATIENT RISK FACTOR | COMMON FUNGAL INFECTION |
---|---|
Human immunodeficiency virus infection (acquired immunodeficiency syndrome) | Candidiasis, cryptococcosis, aspergillosis |
Recent organ transplantation | Candidiasis, aspergillosis |
Neutropenia | Candidiasis, aspergillosis |
High-dose steroids | Zygomycosis, candidiasis |
Recent antibiotic treatment | Candidiasis |
Diabetes | Candidiasis, zygomycosis |
Recent or ongoing hospitalization | Candidiasis, aspergillosis |
Recent abdominal surgery or burns (especially with intensive care unit stay) | Candidiasis |
Travel to endemic area | Histoplasmosis, blastomycosis, coccidioidomycosis |
Organ-Specific Clinical Findings
Pulmonary Disorders
Patients with fungal pneumonia present similarly to patients with other types of pneumonia. They have fever, dry or productive cough, fatigue, shortness of breath, or hemoptysis. The chest radiographic appearance also resembles that of other pneumonias. No specific finding is associated with particular fungal infections; lobar and interstitial infiltrates are both common. Certain fungal infections occasionally manifest with visible masslike lesions (e.g., blastomycosis, aspergillosis), and other infections form cavitary lesions (e.g., sporotrichosis), but these are the exception and not the rule. Fungal pneumonia causes varying symptoms and radiologic appearances. In one review,3 aspergillosis was the most common fungal cause of pneumonia in patients with cancer. Other reviews reported aspergillosis as the most common cause of pneumonia in immunocompromised patients. Healthy, immunocompetent individuals are overwhelmingly more likely to have one of the endemic fungal infections.
Sepsis
Fungal sepsis is rare, but it is highly fatal. The Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) trial4 demonstrated a fungal sepsis mortality rate of nearly 56% that was more than double the nonfungal sepsis mortality rate of 28% to 30%. Suspicion is necessary to identify these patients early. A patient with a history of recent hospitalization, immunosuppression from organ transplants, or abdominal surgery has a dramatically increased risk of disseminated fungal infection causing sepsis. Cultures with specific fungal organism media should be sent, followed by initiation of antifungal therapy.
Cutaneous Disorders
The most common fungal infections in humans are the superficial cutaneous fungal infections (e.g., tinea), which are detailed in Chapter 184. Certain fungal species may start as cutaneous lesions and disseminate to invasive disease, or they may begin as pulmonary disease and disseminate to form cutaneous lesions. The latter type is a form of blastomycosis characterized by a primary pulmonary infection that spreads, leading to cutaneous lesions in 75% of patients with disseminated disease. Sporotrichosis behaves similarly, but in an opposite fashion, because most patients with disseminated disease initially have cutaneous lesions. Both infections manifest as raised verrucous lesions with irregular borders that are painless and are often seen on the face or neck. Either infection can develop into the verrucous form or can become an extremity ulcer. Potassium hydroxide (KOH) scraping identifies these lesions as fungal.
Specific Fungal Infections
Blastomycosis
Blastomycosis is caused by the fungus Blastomyces dermatitidis. This infection occurs primarily in healthy individuals who are exposed in one of the endemic areas (Table 176.2). Pulmonary infections are typical, especially in the acute phase, and are contracted though inhalation of the dormant form. After attaining body temperature, the organism transforms into the yeast form and develops a greater ability to infect. Many patients acquire the infection and have chronic pneumonia for years, often diagnosed as reactive airway disease, before the infection is discovered. Patients with chronic pulmonary infections often develop extrapulmonary manifestations of the disease. These patients frequently have cutaneous lesions, and frank meningitis occurs in 10% of disseminated cases. If CNS involvement is suspected, a simple lumbar puncture is inadequate because results are routinely negative; ventricular fluid collection is required to confirm the diagnosis.
FUNGUS | ENDEMIC AREA |
---|---|
Coccidioides | Southwestern United States |
Blastomyces | Mississippi, St. Lawrence, and Ohio River valleys |
Histoplasma | Mississippi and Ohio River valleys |
Priority Actions
Differential Diagnosis
Shortness of Breath or Productive Cough?
Does the patient have evidence of pneumonia that did not respond to antibiotics?